Usefulness of fluorine-18 fluoro-2-deoxyglucose positron emission tomography for diagnosis and therapy assessment of cardiac sarcoidosis
Ishida, Y.; Nakatani, S.; Tachibana, T.
Journal of Cardiology 35(4): 301-304
2000
ISSN/ISBN: 0914-5087 PMID: 10791274 Document Number: 524010
Document emailed within 1 workday
Related Documents
Tsai, M-Hsui.; Huang, W-Sheng.; Tsai, J.J.; Chen, Y-Kung.; Changlai, S-Pin.; Kao, C-Hung. 2003: Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings Anticancer Research 23(4): 3513-3516Soepenberg, O. 2000: Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology Nederlands Tijdschrift Voor Geneeskunde 144(41): 1979-1980
Tamam, M.O.; Mulazimoglu, M.; Guveli, T.K.; Tamam, C.; Eker, O.; Ozpacaci, T. 2012: Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin European Review for Medical and Pharmacological Sciences 16(15): 2120-2130
Omernik, A. 2012: Role of positron emission tomography in diagnosis and monitoring of sarcoidosis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 33(194): 107-111
Itoh, M.; Kikuchi, R.; Uruma, T.; Tsuji, T.; Kuroda, Y.; Watanabe, H.; Nakamura, H.; Aoshiba, K. 2014: All-in-one imaging of polymyositis, lung cancer and its metastatic lesions by fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography Acta Reumatologica Portuguesa 39(3): 283-284
Yang, Z.; Shi, W.; Zhu, B.; Hu, S.; Zhang, Y.; Wang, M.; Zhang, J.; Yao, Z.; Zhang, Y. 2012: Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography Journal of Otolaryngology - Head and Neck Surgery 41(5): 327-333
Umesaki, N.; Tanaka, T.; Miyama, M.; Ogita, S.; Ochi, H. 2001: Usefulness of positron emission tomography for diagnosis of malignancy in a calcified lesion: a case report European Journal of Gynaecological Oncology 22(4): 263-265
Kobayashi, N.; Fujita, K.; Fujisawa, T.; Takahashi, H.; Yoneda, M.; Abe, Y.; Inamori, M.; Kirikoshi, H.; Kubota, K.; Saito, S.; Nakajima, A. 2008: Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 65-70
Hoekstra, C.J.; Hoekstra, O.S.; Teengs, J.P.; Postmus, P.E.; Smit, E.F. 1999: Thoracic actinomycosis imaging with fluorine-18 fluorodeoxyglucose positron emission tomography Clinical Nuclear Medicine 24(7): 529-530
Mantaka, P.; Strauss, A.D.; Strauss, L.G.; Moehler, M.; Goldschmidt, H.; Oberdorfer, F.; Kontaxakis, G.; Van Kaick, G. 1999: Detection of treated liver metastases using fluorine-18-fluordeoxyglucose (FDG) and positron emission tomography (PET) Anticancer Research 19(5c): 4443-4450
Agus, D.B.; Golde, D.W.; Sgouros, G.; Ballangrud, A.; Cordon-Cardo, C.; Scher, H.I. 1998: Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal Cancer Research 58(14): 3009-3014
Seitz, U.; Wagner, M.; Vogg, A.T.; Glatting, G.; Neumaier, B.; Greten, F.R.; Schmid, R.M.; Reske, S.N. 2001: In vivo evaluation of 5-[(18)F]fluoro-2'-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model Cancer Research 61(10): 3853-3857
Yamamoto, Y.; Nonogi, H. 1994: Evaluation of myocardial viability in patients with old myocardial infarction using 18F-deoxyglucose and positron emission tomography Nihon Rinsho. Japanese Journal of Clinical Medicine 52 Suppl (Part 2): 873-876
Fudo, T.; Kambara, H.; Hashimoto, T.; Hayashi, M.; Tamaki, N.; Yonekura, Y.; Yamashita, K.; Konishi, J.; Tamaki, S.; Kawai, C. 1989: Usefulness of exercise Tl-201 myocardial scintigraphy: comparison with positron emission tomography Journal of Cardiology 19(4): 1053-1060
Verhagen, A.; Elsinga, P.H.; de Groot, T.J.; Paans, A.M.; de Goeij, C.J.; Sluyser, M.; Vaalburg, W. 1991: A fluorine-18 labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomography Cancer Research 51(7): 1930-1933
Chen, M.Y.; Ng, K.K.; Ma, S.Y.; Wu, T.I.; Chang, T.C.; Lai, C.H. 2005: False-positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography imaging caused by retained gauze in a woman with recurrent ovarian cancer: a case report European Journal of Gynaecological Oncology 26(4): 451-453
Okusu, Y.; Ishikawa, T.; Takahashi, N.; Oka, T.; Sumita, S.; Kobayashi, T.; Matsushita, K.; Yamakawa, Y.; Uchino, K.; Matsubara, S.; Kimura, K.; Inoue, T.; Umemura, S. 2002: Efficacy of biventricular pacing on myocardial glucose metabolism in a patient with heart failure using 2-deoxy-2[18F]fluoro-d-glucose positron emission tomography: a case report Journal of Cardiology 39(3): 165-170
Blomqvist, G.; Stone-Elander, S.; Halldin, C.; Roland, P.E.; Swahn, C.G.; Haaparanta, M.; Solin, O.; Lindqvist, M.; Widén, L. 1991: Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose Acta Radiologica. Supplementum 376: 171-172
Liu, F.-l.; Hong, Q.-y.; Shi, H.-c.; Gu, Y.-c.; Bai, C.-x. 2013: Value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in early diagnosis of lung cancer Zhonghua Yi Xue Za Zhi 93(38): 3019-3022
Muckart, D.; Hardcastle, T.; Peer, F. 2016: Positron emission tomography/computed tomography scanning for the diagnosis of occult sepsis in the critically injured South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 54(1): 43-48